MediPal Holdings Corporation
7459
Rang in Aktien
#4271
Medipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898,... Medipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898, primarily specializes in the wholesale distribution of prescription pharmaceuticals throughout Japan. The firm procures a broad spectrum of healthcare products, including medical equipment, materials, and clinical diagnostic reagents, utilized across diagnostics, testing, treatment, and administration, often from the pre-symptomatic stage. It also offers contract-based post-marketing surveillance (PMS) services to manufacturers and strategically invests in products like orphan drugs. Beyond pharmaceuticals, Medipal Holdings diversifies its wholesale activities to encompass cosmetics, daily necessities, and over-the-counter medications. Its extensive product portfolio further includes animal health products for companion animals, raw materials for food processing in the agricultural, fisheries, and livestock sectors, along with livestock feed additives, various seasonings, veterinary medical equipment, packaging materials, and industrial chemicals. The company also provides a comprehensive suite of specialized services. These include conducting contract epidemiological and clinical studies, creating computerized databases for medical supplies and master product data for healthcare facilities, and offering health insurance claims reviews, medical coding dispatch, outsourcing, and remote education. Medipal's operations extend to life and non-life insurance agency services, cleaning management, the full management and operation of distribution centers, commissioned delivery, and worker dispatch. Additionally, it handles the planning, management, administration, and product/service development for its branded Class A health dispensing pharmacies. Serving an expansive client base, Medipal Holdings partners with hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company adopted its current name, Medipal Holdings Corporation in October 2009, having previously operated as Mediceo Paltac Holdings Co., Ltd.
Aktienkurs
$20.40
Marktkapitalisierung
$3.70B
Veränderung (1 Tag)
0.42%
Veränderung (1 Jahr)
19.72%
Land
JP
Handel MediPal Holdings Corporation (7459)
Kategorie
Healthcare
Gewinn für MediPal Holdings Corporation (7459)
Gewinn im Jun 2026 TTM: $566.82M
Laut den aktuellen Finanzberichten von MediPal Holdings Corporation betragen die aktuellen Gewinne des Unternehmens $566.82M. Im Jahr 2024 erzielte das Unternehmen einen Gewinn von $493.81M, ein Rückgang im Vergleich zu dem Gewinn im Jahr 2023, der $527.67M betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von MediPal Holdings Corporation von 2005 bis 2026
Gewinn am Ende jedes Jahres
| Jahr | Gewinn | ändert |
|---|---|---|
| 2026 (TTM) | $566.82M | 10.73% |
| 2025 | $511.91M | 3.67% |
| 2024 | $493.81M | -6.42% |
| 2023 | $527.67M | 12.16% |
| 2022 | $470.47M | 5.83% |
| 2021 | $444.54M | -36.73% |
| 2020 | $702.58M | 22.89% |
| 2019 | $571.72M | -4.29% |
| 2018 | $597.34M | 26.84% |
| 2017 | $470.92M | -3.32% |
| 2016 | $487.10M | 30.05% |
| 2015 | $374.55M | -20.35% |
| 2014 | $470.25M | 11.05% |
| 2013 | $423.44M | 36.15% |
| 2012 | $311.02M | 198.45% |
| 2011 | $104.21M | 12.08% |
| 2010 | $92.98M | -57.61% |
| 2009 | $219.33M | -49.30% |
| 2008 | $432.61M | 48.62% |
| 2007 | $291.08M | 13.73% |
| 2006 | $255.94M | 41.92% |
| 2005 | $180.33M | 0.00% |
Gewinn ähnlicher Unternehmen oder Konkurrenten
| Unternehmen | Gewinn | Gewinnunterschied | Land |
|---|---|---|---|
| $6.46B | 1,039.34% |
US
|
|
| - | - |
US
|
|
| $2.17B | 283.54% |
US
|
|
| - | - |
US
|
|
| $708.86M | 25.06% |
AU
|
